Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
复制标题
DOI:
10.3748/wjg.v27.i41.7173
复制
发表时间:
2021-11-07
影响因子:
4.3
通讯作者:
Ma XL
中科院分区:
文献类型:
--
作者:
Tang YY;Zhao YN;Zhang T;Chen ZY;Ma XL
Combined hepatocellular carcinoma (HCC) and cholangiocarcinoma (cHCC-CCA) is defined as a single nodule showing differentiation into HCC and intrahepatic cholangiocarcinoma and has a poor prognosis. To develop a radiomics nomogram for predicting post-resection survival of patients with cHCC-CCA. Patients with pathologically diagnosed cHCC-CCA were randomly divided into training and validation sets. Radiomics features were extracted from portal venous phase computed tomography (CT) images using the least absolute shrinkage and selection operator Cox regression and random forest analysis. A nomogram integrating the radiomics score and clinical factors was developed using univariate analysis and multivariate Cox regression. Nomogram performance was assessed in terms of the C-index as well as calibration, decision, and survival curves. CT and clinical data of 118 patients were included in the study. The radiomics score, vascular invasion, anatomical resection, total bilirubin level, and satellite lesions were found to be independent predictors of overall survival (OS) and were therefore included in an integrative nomogram. The nomogram was more strongly associated with OS (hazard ratio: 8.155, 95% confidence interval: 4.498-14.785, P < 0.001) than a model based on the radiomics score or only clinical factors. The area under the curve values for 1-year and 3-year OS in the training set were 0.878 and 0.875, respectively. Patients stratified as being at high risk of poor prognosis showed a significantly shorter median OS than those stratified as being at low risk (6.1 vs 81.6 mo, P < 0.001). This nomogram may predict survival of cHCC-CCA patients after hepatectomy and therefore help identify those more likely to benefit from surgery.
登录
查看更多内容
影响因子:
2.1
作者:
Peng, Jie;Zhang, Jing;Liu, Li
通讯作者:
Liu, Li
DOI:
10.1016/s1499-3872(14)60275-7
发表时间:
2014-12-15
影响因子:
3.3
作者:
Lee, Seung Duk;Park, Sang-Jae;Hong, Eun Kyung
通讯作者:
Hong, Eun Kyung
DOI:
10.1007/s00432-019-03062-3
发表时间:
2019-10-29
影响因子:
3.6
作者:
Huang, Xialing;Long, Liling;Chai, Xiangfei
通讯作者:
Chai, Xiangfei
影响因子:
5.9
作者:
Ji, Gu-Wei;Zhu, Fei-Peng;Wang, Xue-Hao
通讯作者:
Wang, Xue-Hao
DOI:
10.1016/s1470-2045(14)71116-7
发表时间:
2015-04
期刊:
The Lancet. Oncology
影响因子:
--
作者:
Balachandran VP;Gonen M;Smith JJ;DeMatteo RP
通讯作者:
DeMatteo RP